CS
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10 | Cell death and disease | 2025 | 34 | 12 | |||
| Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver | JHEP reports | 2025 | 120 | 158 | |||
| Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium | JCI insight | 2023 | 301 | 123 | |||
| ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance | Scientific reports | 2023 | 177 | 85 | |||
| TIA1 loss exacerbates fatty liver disease but exerts a dual role in hepatocarcinogenesis | Cancers | 2022 | 282 | 263 | |||
| Hepatic PTEN signaling regulates systemic metabolic homeostasis through hepatokines-mediated liver-to-peripheral organs crosstalk | International journal of molecular sciences | 2022 | 185 | 142 | |||
| MiR-22 deficiency fosters hepatocellular carcinoma development in fatty liver | Cells | 2022 | 266 | 148 | |||
| The emerging role of stress granules in hepatocellular carcinoma | International Journal of Molecular Sciences | 2021 | 251 | 248 | |||
| GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling | Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids | 2021 | 300 | 217 | |||
| Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis | Cancers | 2021 | 254 | 397 | |||
| S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development | Gut | 2020 | 352 | 1,428 | |||
| Tristetraprolin promotes hepatic inflammation and tumor initiation but restrains cancer progression to malignancy | Cellular and Molecular Gastroenterology and Hepatology | 2020 | 286 | 204 | |||
| Genetic ablation of MiR-22 fosters diet-induced obesity and NAFLD development | Journal of Personalized Medicine | 2020 | 353 | 206 | |||
| GDF11 induces mild hepatic fibrosis independent of metabolic health | Aging | 2020 | 281 | 296 | |||
| mRNA post-transcriptional regulation by AU-rich element-binding proteins in liver inflammation and cancer | International Journal of Molecular Sciences | 2020 | 360 | 82 | |||
| Deciphering miRNAs' action through miRNA editing | International Journal of Molecular Sciences | 2019 | 238 | 215 | |||
| miRNAs and NAFLD: from pathophysiology to therapy | Gut | 2019 | 428 | 2,424 | |||
| Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein | Liver International | 2019 | 459 | 315 | |||
| Hydroxysteroid (17β) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice | FASEB Journal | 2018 | 499 | 4 | |||
| MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers | PPAR Research | 2017 | 521 | 3 | |||
| Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption | Gut | 2016 | 760 | 0 | |||
| MicroRNAs in fatty liver disease | Seminars in liver disease | 2015 | 544 | 2 |
